+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bladder Cancer"

From
Bladder Cancer: Update Bulletin #2 - Product Thumbnail Image

Bladder Cancer: Update Bulletin #2

  • Newsletter
  • September 2023
  • Global
From
Oncology Biomarkers: Global Markets - Product Thumbnail Image

Oncology Biomarkers: Global Markets

  • Report
  • June 2023
  • 186 Pages
  • Global
From
Oncologists Global Market Report 2023 - Product Thumbnail Image

Oncologists Global Market Report 2023

  • Report
  • May 2023
  • 250 Pages
  • Global
From
Oncology Nutrition Global Market Report 2023 - Product Thumbnail Image

Oncology Nutrition Global Market Report 2023

  • Report
  • March 2023
  • 200 Pages
  • Global
From
From
From
From
From
2022 ASCO Weekend Update - Product Thumbnail Image

2022 ASCO Weekend Update

  • Newsletter
  • September 2023
  • 88 Pages
  • Global
From
Loading Indicator

Bladder cancer is a type of cancer that affects the urinary bladder. It is the sixth most common type of cancer in the United States and the fourth most common type of cancer in Europe. Symptoms of bladder cancer include blood in the urine, pain during urination, and frequent urination. Treatment options for bladder cancer include surgery, chemotherapy, radiation therapy, and immunotherapy. The oncology market for bladder cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are developing new treatments to improve outcomes for patients, such as targeted therapies and immunotherapies. Additionally, research is being conducted to better understand the biology of bladder cancer and to develop new diagnostic tests. Companies in the bladder cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more